A new Ozempic lawsuit filed in federal court alleges that the blockbuster diabetes and weight loss drug caused a Massachusetts man to suffer permanent vision loss after developing non-arteritic anterior ischemic optic neuropathy (NAION), a condition that damages the optic nerve and can lead to blindness
Rachael Degurse, CEO of Pearl Primary Care, echoed this insight, sharing that she recommends consumers using GLP-1s focus on the kinds of foods theyre eating and their respective attributes, particularly those packed with protein
If budget is a constraint, use an insulated case with four gel packs (two active, two spare in a hotel freezer) and rotate them every 4-6 hours
These medicines have not been approved for use in people with Type 1 diabetes, although researchers are currently studying the safety and effectiveness for people with Type 1
Effectiveness of semaglutide and tirzepatide in overweight and obese adults with type 1 diabetes
Heres a closer look